Bone mass measurement and bone metabolism in rheumatoid arthritis: A review

Research output: Contribution to journalArticle

214 Citations (Scopus)

Abstract

The involvement of bone in rheumatoid arthritis (RA) is well recognized, and hand bone densitometry appears to be a promising new technique to monitor disease progression by assessing serial changes in hand bone mass in patients with RA. New biochemical markers of bone formation (i.e. osteocalcin) show contradictory results in different studies, although markers of bone resorption (i.e. urinary collagen cross-links) have shown significant increase in patients with RA. Bone histomorphometric studies suggest that the periarticular osteopenia in RA could be related to increased bone turnover locally, whereas generalized osteoporosis could be due to a global negative remodelling balance. The important factors implicated in the pathogenesis of the bone loss are circulating cytokines [e.g. tumour necrosis factor alpha (TNFα), interleukin (IL) 1 and IL6] produced by the inflammatory process, use of oral corticosteroids (in the dose of ≥ 5 mg) and reduced mobility due to functional impairment. Apart from this underlying osteoporosis, patients with RA have an increased risk of falls secondary to functional impairment and there is an increased risk of fractures in patients with RA. Very few studies are presently available looking at the therapeutic measures to prevent osteoporosis in RA. Future drug trials on the treatment of RA should include bone mass measurement, especially of the hand, as one of the outcome measures.

Original languageEnglish (US)
Pages (from-to)309-322
Number of pages14
JournalRevmatologiia
Volume35
Issue number4
StatePublished - Apr 1996
Externally publishedYes

Fingerprint

Rheumatoid Arthritis
Bone and Bones
Hand Bones
Osteoporosis
Densitometry
Bone Remodeling
Metabolic Bone Diseases
Osteocalcin
Bone Resorption
Interleukin-1
Osteogenesis
Disease Progression
Interleukin-6
Adrenal Cortex Hormones
Collagen
Hand
Tumor Necrosis Factor-alpha
Biomarkers
Outcome Assessment (Health Care)
Cytokines

Keywords

  • Bone biochemistry
  • Bone density
  • Bone histomorphometry
  • Corticosteroids
  • Cytokines
  • Fractures
  • Hand bone densitometry
  • Osteoporosis
  • Radiogrammetry
  • Rheumatoid arthritis

ASJC Scopus subject areas

  • Rheumatology
  • Neuroscience(all)

Cite this

Bone mass measurement and bone metabolism in rheumatoid arthritis : A review. / Deodhar, Atulya (Atul); Woolf, A. D.

In: Revmatologiia, Vol. 35, No. 4, 04.1996, p. 309-322.

Research output: Contribution to journalArticle

@article{9460a62159fa45bc86db8435bacdebe0,
title = "Bone mass measurement and bone metabolism in rheumatoid arthritis: A review",
abstract = "The involvement of bone in rheumatoid arthritis (RA) is well recognized, and hand bone densitometry appears to be a promising new technique to monitor disease progression by assessing serial changes in hand bone mass in patients with RA. New biochemical markers of bone formation (i.e. osteocalcin) show contradictory results in different studies, although markers of bone resorption (i.e. urinary collagen cross-links) have shown significant increase in patients with RA. Bone histomorphometric studies suggest that the periarticular osteopenia in RA could be related to increased bone turnover locally, whereas generalized osteoporosis could be due to a global negative remodelling balance. The important factors implicated in the pathogenesis of the bone loss are circulating cytokines [e.g. tumour necrosis factor alpha (TNFα), interleukin (IL) 1 and IL6] produced by the inflammatory process, use of oral corticosteroids (in the dose of ≥ 5 mg) and reduced mobility due to functional impairment. Apart from this underlying osteoporosis, patients with RA have an increased risk of falls secondary to functional impairment and there is an increased risk of fractures in patients with RA. Very few studies are presently available looking at the therapeutic measures to prevent osteoporosis in RA. Future drug trials on the treatment of RA should include bone mass measurement, especially of the hand, as one of the outcome measures.",
keywords = "Bone biochemistry, Bone density, Bone histomorphometry, Corticosteroids, Cytokines, Fractures, Hand bone densitometry, Osteoporosis, Radiogrammetry, Rheumatoid arthritis",
author = "Deodhar, {Atulya (Atul)} and Woolf, {A. D.}",
year = "1996",
month = "4",
language = "English (US)",
volume = "35",
pages = "309--322",
journal = "Revmatologiia (Bulgaria)",
issn = "1310-0505",
publisher = "Meditsiinski Unversitet-Sofia",
number = "4",

}

TY - JOUR

T1 - Bone mass measurement and bone metabolism in rheumatoid arthritis

T2 - A review

AU - Deodhar, Atulya (Atul)

AU - Woolf, A. D.

PY - 1996/4

Y1 - 1996/4

N2 - The involvement of bone in rheumatoid arthritis (RA) is well recognized, and hand bone densitometry appears to be a promising new technique to monitor disease progression by assessing serial changes in hand bone mass in patients with RA. New biochemical markers of bone formation (i.e. osteocalcin) show contradictory results in different studies, although markers of bone resorption (i.e. urinary collagen cross-links) have shown significant increase in patients with RA. Bone histomorphometric studies suggest that the periarticular osteopenia in RA could be related to increased bone turnover locally, whereas generalized osteoporosis could be due to a global negative remodelling balance. The important factors implicated in the pathogenesis of the bone loss are circulating cytokines [e.g. tumour necrosis factor alpha (TNFα), interleukin (IL) 1 and IL6] produced by the inflammatory process, use of oral corticosteroids (in the dose of ≥ 5 mg) and reduced mobility due to functional impairment. Apart from this underlying osteoporosis, patients with RA have an increased risk of falls secondary to functional impairment and there is an increased risk of fractures in patients with RA. Very few studies are presently available looking at the therapeutic measures to prevent osteoporosis in RA. Future drug trials on the treatment of RA should include bone mass measurement, especially of the hand, as one of the outcome measures.

AB - The involvement of bone in rheumatoid arthritis (RA) is well recognized, and hand bone densitometry appears to be a promising new technique to monitor disease progression by assessing serial changes in hand bone mass in patients with RA. New biochemical markers of bone formation (i.e. osteocalcin) show contradictory results in different studies, although markers of bone resorption (i.e. urinary collagen cross-links) have shown significant increase in patients with RA. Bone histomorphometric studies suggest that the periarticular osteopenia in RA could be related to increased bone turnover locally, whereas generalized osteoporosis could be due to a global negative remodelling balance. The important factors implicated in the pathogenesis of the bone loss are circulating cytokines [e.g. tumour necrosis factor alpha (TNFα), interleukin (IL) 1 and IL6] produced by the inflammatory process, use of oral corticosteroids (in the dose of ≥ 5 mg) and reduced mobility due to functional impairment. Apart from this underlying osteoporosis, patients with RA have an increased risk of falls secondary to functional impairment and there is an increased risk of fractures in patients with RA. Very few studies are presently available looking at the therapeutic measures to prevent osteoporosis in RA. Future drug trials on the treatment of RA should include bone mass measurement, especially of the hand, as one of the outcome measures.

KW - Bone biochemistry

KW - Bone density

KW - Bone histomorphometry

KW - Corticosteroids

KW - Cytokines

KW - Fractures

KW - Hand bone densitometry

KW - Osteoporosis

KW - Radiogrammetry

KW - Rheumatoid arthritis

UR - http://www.scopus.com/inward/record.url?scp=0029868840&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029868840&partnerID=8YFLogxK

M3 - Article

C2 - 8624634

AN - SCOPUS:0029868840

VL - 35

SP - 309

EP - 322

JO - Revmatologiia (Bulgaria)

JF - Revmatologiia (Bulgaria)

SN - 1310-0505

IS - 4

ER -